Excess weight and associated risk factors in patients with systemic lupus erythematosus.

scientific article published on 22 April 2012

Excess weight and associated risk factors in patients with systemic lupus erythematosus. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1023063278
P356DOI10.1007/S00296-012-2402-8
P8608Fatcat IDrelease_4xcuhacqqbbsrhsvbyp76udkjy
P698PubMed publication ID22527136

P2093author name stringMaria Isabel T D Correia
Rosa Weiss Telles
Cristina Costa Duarte Lanna
Mariane Curado Borges
Fabiana de Miranda Moura dos Santos
P2860cites workClinical practice. Primary ovarian insufficiencyQ24653014
Prevalence of overweight and obesity in the United States, 1999-2004Q28305811
The 1982 revised criteria for the classification of systemic lupus erythematosusQ29547225
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosusQ29614922
International physical activity questionnaire: 12-country reliability and validityQ29615137
The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected].Q31114844
Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus CohortQ33915430
Methotrexate in systemic lupus erythematosusQ36063859
Systemic lupus erythematosus and exerciseQ36729461
Anthropometric reference data for international use: recommendations from a World Health Organization Expert CommitteeQ36823478
Regulatory role of G protein-coupled estrogen receptor for vascular function and obesityQ37435268
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosusQ40974327
Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.Q41109148
Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrualQ41912319
Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapyQ41919785
Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge.Q42771406
Metabolic syndrome in Argentinean patients with systemic lupus erythematosus.Q43275139
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.Q43417859
Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study GroupQ43589680
The 10-year incidence of overweight and major weight gain in US adultsQ43844390
Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesityQ44237948
Methotrexate use in patients with systemic lupus erythematosusQ45078984
Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosusQ46144242
Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trialQ46227344
Metabolic syndrome in patients with systemic lupus erythematosus from Southern SpainQ46404846
Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosusQ48666386
Biochemical characterization of ADP-ribose polymer metabolism in SLE.Q51031046
Prevalence and factors associated with dyslipoproteinemias in Brazilian systemic lupus erythematosus patients.Q51464078
Risk factors for coronary artery disease in patients with systemic lupus erythematosusQ67586359
Socioeconomic status and weight control practices among 20- to 45-year-old womenQ71158521
Fatigue in systemic lupus erythematosus: a randomized controlled trial of exerciseQ73350605
Diagnosis and classification of diabetes mellitusQ75205667
Systemic lupus erythematosus disease activity index 2000Q77624632
Body mass index and the risk of development of end-stage renal disease in a screened cohortQ79933214
[V Brazilian Guidelines in Arterial Hypertension. ]Q81376428
Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosusQ81420605
Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosusQ81602795
P433issue3
P304page(s)681-688
P577publication date2012-04-22
P1433published inRheumatology InternationalQ15763689
P1476titleExcess weight and associated risk factors in patients with systemic lupus erythematosus.
P478volume33

Reverse relations

cites work (P2860)
Q93054220A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases
Q37330468Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.
Q34081242Cardiovascular involvement in autoimmune diseases
Q47216525Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus?
Q98465680Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review
Q35542454Serum Immunoglobulin M Concentration Varies with Triglyceride Levels in an Adult Population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study

Search more.